HCA Holdings, Inc. (HCA) Downgraded to “Hold” at ValuEngine
ValuEngine lowered shares of HCA Holdings, Inc. (NYSE:HCA) from a buy rating to a hold rating in a report issued on Thursday.
Several other equities research analysts have also recently commented on HCA. Morgan Stanley started coverage on HCA Holdings in a research note on Tuesday, June 6th. They set an equal weight rating and a $90.00 price target for the company. Leerink Swann upgraded HCA Holdings from a market perform rating to an outperform rating and upped their price target for the stock from $92.00 to $100.00 in a research note on Tuesday, June 6th. BidaskClub upgraded HCA Holdings from a strong sell rating to a sell rating in a research note on Tuesday, June 13th. Argus started coverage on HCA Holdings in a research note on Wednesday, June 28th. They set a buy rating and a $100.00 price target for the company. Finally, Zacks Investment Research upgraded HCA Holdings from a hold rating to a buy rating and set a $97.00 price target for the company in a research note on Thursday, July 13th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. HCA Holdings currently has a consensus rating of Buy and a consensus price target of $92.81.
HCA Holdings (NYSE HCA) traded up 0.30% during trading on Thursday, reaching $76.60. 975,361 shares of the company’s stock were exchanged. The stock has a 50-day moving average of $79.46 and a 200-day moving average of $83.83. The stock has a market capitalization of $27.67 billion, a PE ratio of 10.27 and a beta of 0.67. HCA Holdings has a 52 week low of $67.00 and a 52 week high of $91.03.
HCA Holdings (NYSE:HCA) last posted its quarterly earnings data on Tuesday, July 25th. The company reported $1.75 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.80 by $0.05. The firm had revenue of $10.73 billion during the quarter, compared to analyst estimates of $10.76 billion. HCA Holdings had a net margin of 6.64% and a negative return on equity of 48.08%. HCA Holdings’s revenue was up 4.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.66 earnings per share. On average, equities research analysts anticipate that HCA Holdings will post $7.19 EPS for the current year.
In other news, insider Jonathan B. Perlin sold 71,063 shares of the firm’s stock in a transaction on Thursday, June 22nd. The stock was sold at an average price of $86.00, for a total value of $6,111,418.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Michael S. Cuffe sold 2,150 shares of the firm’s stock in a transaction on Thursday, June 15th. The shares were sold at an average price of $84.86, for a total value of $182,449.00. The disclosure for this sale can be found here. Insiders sold 77,513 shares of company stock valued at $6,651,455 in the last quarter. 2.90% of the stock is currently owned by company insiders.
Hedge funds have recently made changes to their positions in the company. Northwestern Mutual Wealth Management Co. increased its position in shares of HCA Holdings by 14.0% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock valued at $101,000 after buying an additional 143 shares in the last quarter. Bronfman E.L. Rothschild L.P. increased its position in shares of HCA Holdings by 35.1% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock valued at $107,000 after buying an additional 320 shares in the last quarter. Atlantic Trust LLC purchased a new position in shares of HCA Holdings in the second quarter valued at $118,000. Lee Financial Co purchased a new position in shares of HCA Holdings in the second quarter valued at $125,000. Finally, Acrospire Investment Management LLC increased its position in shares of HCA Holdings by 14.3% in the second quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock valued at $140,000 after buying an additional 200 shares in the last quarter. Institutional investors and hedge funds own 73.77% of the company’s stock.
About HCA Holdings
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Stock Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related stocks with our FREE daily email newsletter.